Open AccessThe Efficacy of Hydroxychloroquine and Azithromycin Combination Therapy on Hospital Mortality in COVID 19 Pneumonia Patients
Author(s) -
Saliha Selin Özuygur Ermiş,
Begüm Ergan,
Özen K. Başoğlu,
Gülsüm Songül Ercan,
Pervin Korkmaz Ekren,
Ziya Kuruüzüm,
Mustafa Hikmet Özhan,
Ayça Arzu Sayıner,
Yusuf Savran,
Şaziye Rüçhan Sertöz,
Mehmet Sezai Taşbakan,
Oğuz Kılınç,
Abdullah Sayıner
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2009-64
Subject(s) - hydroxychloroquine , medicine , azithromycin , pneumonia , mechanical ventilation , intensive care unit , oxygen therapy , combination therapy , covid-19 , intensive care medicine , antibiotics , disease , infectious disease (medical specialty) , microbiology and biotechnology , biology
Effective therapeutic approaches for SARS-CoV-2 pandemic are urgently needed. Hydroxychloroquine (HCQ) alone or in combination with azithromycin has been used in several countries, without any clear evidence. This study aimed to determine the effectiveness and safety of hydroxychloroquine as compared to hydroxychloroquine and azithromycin combination in patients with COVID-19 pneumonia.